1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Global Neurovascular Thrombectomy Devices Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Rising Prevalence of Stroke
3.2.1.2. Growing Geriatric Population
3.2.1.3. Increasing Awareness and Improved Diagnosis
3.2.1.4. Favorable Reimbursement Policies
3.2.2. Restraints
3.2.2.1. High Cost of Devices
3.2.2.2. Limited Medical Expertise
3.2.2.3. Stringent Regulatory Requirements
3.2.3. Opportunities
3.2.3.1. Technological Advancements
3.2.3.2. Emerging Markets
3.2.3.3. Focus on Minimally Invasive Procedures
3.2.4. Challenges
3.2.4.1. Maintaining Procedural Efficiency
3.2.4.2. Reimbursement Challenges in Many Countries
3.2.4.3. Increased Competition
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Global Neurovascular Thrombectomy Devices Market: Marketing Strategies
5. Global Neurovascular Thrombectomy Devices Market Overview
5.1. Market Size & Forecast, 2019-2030
5.1.1. By Value (USD Billion)
5.2. Market Share and Forecast
5.2.1. By Device Type
5.2.1.1. Aspiration Devices
5.2.1.2. Stent Retrievers
5.2.1.3. Mechanical Embolus Removal Devices
5.2.1.4. Suction Devices
5.2.1.5. Others
5.2.2. By Indication
5.2.2.1. Ischemic Stroke
5.2.2.2. Hemorrhagic Stroke
5.2.2.3. Others
5.2.3. By End User
5.2.3.1. Hospitals
5.2.3.2. Ambulatory Surgical Centers
5.2.3.3. Specialty Clinics
5.2.3.4. Others
5.2.4. By Region
5.2.4.1. North America
5.2.4.2. Europe
5.2.4.3. Asia Pacific (APAC)
5.2.4.4. Latin America (LATAM)
5.2.4.5. Middle East and Africa (MEA)
6. North America Neurovascular Thrombectomy Devices Market
6.1. Market Size & Forecast, 2019-2030
6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
6.2.1. By Device Type
6.2.2. By Indication
6.2.3. By End User
6.2.4. By Country
6.2.4.1. United States
6.2.4.1.1. By Device Type
6.2.4.1.2. By Indication
6.2.4.1.3. By End User
6.2.4.2. Canada
6.2.4.2.1. By Device Type
6.2.4.2.2. By Indication
6.2.4.2.3. By End User
7. Europe Neurovascular Thrombectomy Devices Market
7.1. Market Size & Forecast, 2019-2030
7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
7.2.1. By Device Type
7.2.2. By Indication
7.2.3. By End User
7.2.4. By Country
7.2.4.1. Germany
7.2.4.1.1. By Device Type
7.2.4.1.2. By Indication
7.2.4.1.3. By End User
7.2.4.2. United Kingdom
7.2.4.2.1. By Device Type
7.2.4.2.2. By Indication
7.2.4.2.3. By End User
7.2.4.3. Italy
7.2.4.3.1. By Device Type
7.2.4.3.2. By Indication
7.2.4.3.3. By End User
7.2.4.4. France
7.2.4.4.1. By Device Type
7.2.4.4.2. By Indication
7.2.4.4.3. By End User
7.2.4.5. Spain
7.2.4.5.1. By Device Type
7.2.4.5.2. By Indication
7.2.4.5.3. By End User
7.2.4.6. Belgium
7.2.4.6.1. By Device Type
7.2.4.6.2. By Indication
7.2.4.6.3. By End User
7.2.4.7. Russia
7.2.4.7.1. By Device Type
7.2.4.7.2. By Indication
7.2.4.7.3. By End User
7.2.4.8. The Netherlands
7.2.4.8.1. By Device Type
7.2.4.8.2. By Indication
7.2.4.8.3. By End User
7.2.4.9. Rest of Europe
7.2.4.9.1. By Device Type
7.2.4.9.2. By Indication
7.2.4.9.3. By End User
8. Asia Pacific Neurovascular Thrombectomy Devices Market
8.1. Market Size & Forecast, 2019-2030
8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
8.2.1. By Device Type
8.2.2. By Indication
8.2.3. By End User
8.2.4. By Country
8.2.4.1. China
8.2.4.1.1. By Device Type
8.2.4.1.2. By Indication
8.2.4.1.3. By End User
8.2.4.2. India
8.2.4.2.1. By Device Type
8.2.4.2.2. By Indication
8.2.4.2.3. By End User
8.2.4.3. Japan
8.2.4.3.1. By Device Type
8.2.4.3.2. By Indication
8.2.4.3.3. By End User
8.2.4.4. South Korea
8.2.4.4.1. By Device Type
8.2.4.4.2. By Indication
8.2.4.4.3. By End User
8.2.4.5. Australia & New Zealand
8.2.4.5.1. By Device Type
8.2.4.5.2. By Indication
8.2.4.5.3. By End User
8.2.4.6. Indonesia
8.2.4.6.1. By Device Type
8.2.4.6.2. By Indication
8.2.4.6.3. By End User
8.2.4.7. Malaysia
8.2.4.7.1. By Device Type
8.2.4.7.2. By Indication
8.2.4.7.3. By End User
8.2.4.8. Singapore
8.2.4.8.1. By Device Type
8.2.4.8.2. By Indication
8.2.4.8.3. By End User
8.2.4.9. Vietnam
8.2.4.9.1. By Device Type
8.2.4.9.2. By Indication
8.2.4.9.3. By End User
8.2.4.10. Rest of APAC
8.2.4.10.1. By Device Type
8.2.4.10.2. By Indication
8.2.4.10.3. By End User
9. Latin America Neurovascular Thrombectomy Devices Market
9.1. Market Size & Forecast, 2019-2030
9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
9.2.1. By Device Type
9.2.2. By Indication
9.2.3. By End User
9.2.4. By Country
9.2.4.1. Brazil
9.2.4.1.1. By Device Type
9.2.4.1.2. By Indication
9.2.4.1.3. By End User
9.2.4.2. Mexico
9.2.4.2.1. By Device Type
9.2.4.2.2. By Indication
9.2.4.2.3. By End User
9.2.4.3. Argentina
9.2.4.3.1. By Device Type
9.2.4.3.2. By Indication
9.2.4.3.3. By End User
9.2.4.4. Peru
9.2.4.4.1. By Device Type
9.2.4.4.2. By Indication
9.2.4.4.3. By End User
9.2.4.5. Rest of LATAM
9.2.4.5.1. By Device Type
9.2.4.5.2. By Indication
9.2.4.5.3. By End User
10. Middle East and Africa Neurovascular Thrombectomy Devices Market
10.1. Market Size & Forecast, 2019-2030
10.1.1. By Value (USD Billion)
10.2. Market Share & Forecast
10.2.1. By Device Type
10.2.2. By Indication
10.2.3. By End User
10.2.4. By Country
10.2.4.1. Saudi Arabia
10.2.4.1.1. By Device Type
10.2.4.1.2. By Indication
10.2.4.1.3. By End User
10.2.4.2. UAE
10.2.4.2.1. By Device Type
10.2.4.2.2. By Indication
10.2.4.2.3. By End User
10.2.4.3. Qatar
10.2.4.3.1. By Device Type
10.2.4.3.2. By Indication
10.2.4.3.3. By End User
10.2.4.4. Kuwait
10.2.4.4.1. By Device Type
10.2.4.4.2. By Indication
10.2.4.4.3. By End User
10.2.4.5. South Africa
10.2.4.5.1. By Device Type
10.2.4.5.2. By Indication
10.2.4.5.3. By End User
10.2.4.6. Nigeria
10.2.4.6.1. By Device Type
10.2.4.6.2. By Indication
10.2.4.6.3. By End User
10.2.4.7. Algeria
10.2.4.7.1. By Device Type
10.2.4.7.2. By Indication
10.2.4.7.3. By End User
10.2.4.8. Rest of MEA
10.2.4.8.1. By Device Type
10.2.4.8.2. By Indication
10.2.4.8.3. By End User
11. Competitive Landscape
11.1. List of Key Players and Their Offerings
11.2. Global Neurovascular Thrombectomy Devices Market Share Analysis, 2023
11.3. Competitive Benchmarking, By Operating Parameters
11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
12. Impact of Escalating Geopolitical Tensions on Global Neurovascular Thrombectomy Devices Market
13. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
13.1. Acandis GmbH
13.2. Penumbra, Inc.
13.3. Medtronic
13.4. VESALIO, LLC
13.5. Johnson and Johnson
13.6. MicroVention, Inc.
13.7. Phenox GmbH
13.8. Imperative Care, Inc.
13.9. Balt Group
13.10. NeuroVasc Technologies, Inc.
13.11. Baylis Medical Company, Inc.
13.12. Boston Scientific Corporation
13.13. Terumo Corporation
13.14. Spectranetics Corporation
13.15. Edwards Lifesciences Corporation
13.16. Argon Medical Devices, Inc
13.17. Teleflex Incorporated
13.18. Other Prominent Players
14. Key Strategic Recommendations
15. Research Methodology
15.1. Qualitative Research
15.1.1. Primary & Secondary Research
15.2. Quantitative Research
15.3. Market Breakdown & Data Triangulation
15.3.1. Secondary Research
15.3.2. Primary Research
15.4. Breakdown of Primary Research Respondents, By Region
15.5. Assumptions & Limitations